发明名称 |
QUINAZOLINE DERIVATIVE |
摘要 |
<p>A compound represented by the formula (I): ring A (wherein R<1> represents lower alkyl, etc.; R<2> and R<3> are the same or different and each represents hydrogen, etc.; R<4> represents, e.g., a group represented by the formula (II): X1 represents NH, O, or S; Y represents N or C; Ar represents, e.g., a divalent group formed by removing two hydrogen atoms from aryl; and ring A represents a 5- or 6-membered heteroaryl, etc.) or a pharmaceutically acceptable salt of the compound. They have antagonistic activity against a histamine H3 receptor and inverse antagonistic activity against a histamine H3receptor and are useful in the prevention or treatment of metabolic system diseases, circulatory system diseases, or nervous system diseases.</p> |
申请公布号 |
WO2005115993(A1) |
申请公布日期 |
2005.12.08 |
申请号 |
WO2005JP10291 |
申请日期 |
2005.05.30 |
申请人 |
BANYU PHARMACEUTICAL CO., LTD.;MIZUTANI, TAKASHI;NAGASE, TSUYOSHI;SATO, NAGAAKI;KANATANI, AKIO;TOKITA, SHIGERU |
发明人 |
MIZUTANI, TAKASHI;NAGASE, TSUYOSHI;SATO, NAGAAKI;KANATANI, AKIO;TOKITA, SHIGERU |
分类号 |
A61K31/517;A61K31/519;A61P1/16;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/10;A61P9/12;A61P13/12;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/36;A61P43/00;C07D239/91;C07D401/12;C07D403/04;C07D471/04;(IPC1-7):C07D239/91 |
主分类号 |
A61K31/517 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|